ferric maltol has been researched along with Anemias, Iron-Deficiency in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishbane, S; Ganz, T; Pergola, PE | 1 |
| Farland, MZ; Khoury, A; Pagan, KA | 1 |
| Akobeng, AK; Allen, P; Engineer, J; Gordon, M; Hoque, S; Iheozor-Ejiofor, Z; Iqbal, T; Sinopoulou, V | 1 |
| Beales, I; Cummings, JF; Fraser, A; Hoque, S; Sebastian, S; Stansfield, C | 1 |
| Bokemeyer, B; Domènech, E; Howaldt, S; Martinez, N; Schmidt, C | 1 |
| Kopyt, NP; Pergola, PE | 1 |
| Demetriou, T; Kolnagou, A; Kontoghiorghe, CN; Kontoghiorghes, GJ; Neocleous, M | 1 |
| Aksan, A; Dignass, A; Farrag, K; Radeke, HH; Stein, J | 1 |
| Ahmad, T; Baumgart, DC; Bokemeyer, B; Büning, C; Gasche, C; Howaldt, S; Stallmach, A; Tulassay, Z | 1 |
| Büning, C; Stallmach, A | 1 |
| Ahmad, T; Baumgart, DC; Bokemeyer, B; Büning, C; Howaldt, S; Schmidt, C; Stallmach, A; Tulassay, Z | 1 |
| Nanivadekar, AS | 1 |
6 review(s) available for ferric maltol and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Hematinics; Humans; Pyrones; Renal Insufficiency, Chronic | 2019 |
Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Clinical Trials as Topic; Female; Ferric Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Renal Insufficiency, Chronic; Treatment Outcome | 2021 |
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Bias; Colitis, Ulcerative; Crohn Disease; Disaccharides; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fumarates; Hematinics; Humans; Iron Compounds; Maltose; Middle Aged; Placebos; Pyrones; Randomized Controlled Trials as Topic; Young Adult | 2021 |
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.
Topics: Anemia, Iron-Deficiency; Animals; Biological Availability; Ferric Compounds; Humans; In Vitro Techniques; Iron; Iron Chelating Agents; Pyrones | 2021 |
Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Inflammation; Inflammatory Bowel Diseases; Iron; Prognosis; Pyrones | 2017 |
Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Clinical Trials, Phase III as Topic; Ferric Compounds; Ferrous Compounds; Humans; Inflammatory Bowel Diseases; Pyrones; Quality of Life; Randomized Controlled Trials as Topic | 2015 |
4 trial(s) available for ferric maltol and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Treatment Outcome | 2022 |
Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Iron Deficiencies; Pyrones; Renal Insufficiency, Chronic | 2021 |
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Female; Ferric Compounds; Hemoglobins; Humans; Male; Maximum Tolerated Dose; Prognosis; Pyrones; Quality of Life | 2015 |
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Female; Ferric Compounds; Hemoglobins, Abnormal; Humans; Inflammatory Bowel Diseases; Iron; Male; Middle Aged; Pyrones | 2016 |
2 other study(ies) available for ferric maltol and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hospitals; Humans; Inflammatory Bowel Diseases; Male; Pyrones; Retrospective Studies; United Kingdom | 2021 |
Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Child; Female; Ferric Compounds; Humans; Male; Middle Aged; Pyrones; Treatment Failure | 2003 |